Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109666543> ?p ?o ?g. }
- W2109666543 endingPage "966" @default.
- W2109666543 startingPage "938" @default.
- W2109666543 abstract "Parkinson's disease is a debilitating movement disorder characterized by a generalized dysfunction of the nervous system, with a particularly prominent decline in the nigrostriatal dopaminergic pathway. Although there is currently no cure, drugs targeting the dopaminergic system provide major symptomatic relief. As well, agents directed to other neurotransmitter systems are of therapeutic benefit. Such drugs may act by directly improving functional deficits in these other systems, or they may restore aberrant motor activity that arises as a result of a dopaminergic imbalance. Recent research attention has focused on a role for drugs targeting the nicotinic cholinergic systems. The rationale for such work stems from basic research findings that there is an extensive overlap in the organization and function of the nicotinic cholinergic and dopaminergic systems in the basal ganglia. In addition, nicotinic acetylcholine receptor (nAChR) drugs could have clinical potential for Parkinson's disease. Evidence for this proposition stems from studies with experimental animal models showing that nicotine protects against neurotoxin-induced nigrostriatal damage and improves motor complications associated with l-DOPA, the gold standard for Parkinson's disease treatment. Nicotine interacts with multiple central nervous system receptors to generate therapeutic responses but also produces side effects. It is important therefore to identify the nAChR subtypes most beneficial for treating Parkinson's disease. Here we review nAChRs with particular emphasis on the subtypes that contribute to basal ganglia function. Accumulating evidence suggests that drugs targeting α6β2* and α4β2* nAChR may prove useful in the management of Parkinson's disease." @default.
- W2109666543 created "2016-06-24" @default.
- W2109666543 creator A5022945644 @default.
- W2109666543 creator A5025249043 @default.
- W2109666543 date "2011-10-03" @default.
- W2109666543 modified "2023-10-14" @default.
- W2109666543 title "α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease" @default.
- W2109666543 cites W138483743 @default.
- W2109666543 cites W1495806335 @default.
- W2109666543 cites W1513720278 @default.
- W2109666543 cites W1531095018 @default.
- W2109666543 cites W1557320868 @default.
- W2109666543 cites W1560891849 @default.
- W2109666543 cites W1579854617 @default.
- W2109666543 cites W1584149994 @default.
- W2109666543 cites W1594311145 @default.
- W2109666543 cites W1598962518 @default.
- W2109666543 cites W1622774380 @default.
- W2109666543 cites W1633847368 @default.
- W2109666543 cites W1651595496 @default.
- W2109666543 cites W1665332641 @default.
- W2109666543 cites W1764026126 @default.
- W2109666543 cites W1799696262 @default.
- W2109666543 cites W1829037758 @default.
- W2109666543 cites W1840984304 @default.
- W2109666543 cites W1884123732 @default.
- W2109666543 cites W1885050361 @default.
- W2109666543 cites W1896132173 @default.
- W2109666543 cites W1900806927 @default.
- W2109666543 cites W1900863549 @default.
- W2109666543 cites W1908660545 @default.
- W2109666543 cites W1908865100 @default.
- W2109666543 cites W1926699758 @default.
- W2109666543 cites W1933235205 @default.
- W2109666543 cites W1949404224 @default.
- W2109666543 cites W1964188222 @default.
- W2109666543 cites W1965109264 @default.
- W2109666543 cites W1965181130 @default.
- W2109666543 cites W1966092923 @default.
- W2109666543 cites W1966443363 @default.
- W2109666543 cites W1967579836 @default.
- W2109666543 cites W1968189433 @default.
- W2109666543 cites W1969781363 @default.
- W2109666543 cites W1970133822 @default.
- W2109666543 cites W1973059761 @default.
- W2109666543 cites W1973740048 @default.
- W2109666543 cites W1974026398 @default.
- W2109666543 cites W1974110266 @default.
- W2109666543 cites W1974183957 @default.
- W2109666543 cites W1974840438 @default.
- W2109666543 cites W1974896225 @default.
- W2109666543 cites W1974931223 @default.
- W2109666543 cites W1976679890 @default.
- W2109666543 cites W1977151466 @default.
- W2109666543 cites W1977353877 @default.
- W2109666543 cites W1977567629 @default.
- W2109666543 cites W1977859379 @default.
- W2109666543 cites W1978071150 @default.
- W2109666543 cites W1978318953 @default.
- W2109666543 cites W1978571393 @default.
- W2109666543 cites W1979166352 @default.
- W2109666543 cites W1979212481 @default.
- W2109666543 cites W1979668360 @default.
- W2109666543 cites W1980202815 @default.
- W2109666543 cites W1980253122 @default.
- W2109666543 cites W1980567992 @default.
- W2109666543 cites W1980666407 @default.
- W2109666543 cites W1981632227 @default.
- W2109666543 cites W1982164956 @default.
- W2109666543 cites W1982378333 @default.
- W2109666543 cites W1982429100 @default.
- W2109666543 cites W1983365362 @default.
- W2109666543 cites W1985578899 @default.
- W2109666543 cites W1985905363 @default.
- W2109666543 cites W1986122184 @default.
- W2109666543 cites W1986445622 @default.
- W2109666543 cites W1986694134 @default.
- W2109666543 cites W1987029855 @default.
- W2109666543 cites W1987446689 @default.
- W2109666543 cites W1987928754 @default.
- W2109666543 cites W1989327482 @default.
- W2109666543 cites W1989866073 @default.
- W2109666543 cites W1990989480 @default.
- W2109666543 cites W1991603311 @default.
- W2109666543 cites W1993112595 @default.
- W2109666543 cites W1993742630 @default.
- W2109666543 cites W1994350928 @default.
- W2109666543 cites W1994576976 @default.
- W2109666543 cites W1994720205 @default.
- W2109666543 cites W1994984635 @default.
- W2109666543 cites W1995082893 @default.
- W2109666543 cites W1995472799 @default.
- W2109666543 cites W1996040347 @default.
- W2109666543 cites W1996065721 @default.
- W2109666543 cites W1997230575 @default.
- W2109666543 cites W1997437727 @default.
- W2109666543 cites W1997727963 @default.
- W2109666543 cites W2000704448 @default.